Germany · Series D startup

Who invested in MedAble

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$304Mraised across 2 rounds since 2015, from 2 sources

$300KSeed$304MSeries D

Latest round: Series D, $304MOct 2021
Step-upi: 1013.3×
Investors: 5

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015201620172018201920202021

$300KSeed$304MSeries D

First round: Seed, $300K
Biggest round: $304M
Between rounds: 6.6 years

MedAbleClinical trials1 / 15Their pitch deckMedAble's pitch deck, 15 slidesEach slide read for what it argues, against the decks that raised at the same stage.

The rounds

Oct 2021
Series D$304M4 new
Source recordedSEC filing: $304M sold, first sale Sept 2021
Mar 2015
Seed$300K1 new
- Streamlined Ventures
From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2015Series D2021

GSR

Sapphire Ventures

Western Technology Investment

Streamlined Ventures

Obvious Ventures

Everyone who backed them

GSRVC firm1round

Sapphire VenturesVC firm1round

Western Technology InvestmentVC firm1round

Streamlined VenturesVC firm1round

Obvious VenturesAccelerator1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists MedAble as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.